Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|March 3, 2009
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection modelUrs A Ochsner, Stacie J Bell, Ann L O'Leary, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United StatesMichael R Jacobs, Caryn E Good, Anne R Windau, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosaWright W Nichols, Gregory G Stone, Paul Newell, et al.
Open Forum Infectious Diseases|May 2, 2019
Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End PointsAntoni Torres, Doug Rank, David Melnick, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniaeScott A Van Wart, Paul G Ambrose, Christopher M Rubino, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaDonald E Low, Thomas M File, Paul B Eckburg, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaThomas M File, Donald E Low, Paul B Eckburg, et al.
The Lancet. Microbe|March 3, 2024
Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trialTsegaye Sewunet, Mohammad Razavi, Staffan Rosenborg, et al.
The New England Journal of Medicine|April 7, 2022
Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract InfectionPaul B Eckburg, Lori Muir, Ian A Critchley, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009Sandra S Richter, Kristopher P Heilmann, Cassie L Dohrn, et al.
Pageof 6